Inventor · disambiguated record
Piergiorgio Francesco Tommaso Pettazzoni
Also filed as: PETTAZZONI PIERGIORGIO FRANCESCO TOMMASO
2 granted patents·7 pending applications·0 citations·filing 2022–2025
29Inventor score
Top patents by PatentIndex Score
9 records- 0181US12486253B2Therapeutics for the degradation of mutant BRAFC4 THERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·0 cites·4 claims
- 0271US12116349B2Methylquinazolinone derivativesHOFFMANN LA ROCHE·Filed 2022·Granted Oct 15, 2024·0 cites·54 claims
- 0370US2024174621A1Methylquinazolinone derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0463US2024139192A1Methods and compositions comprising a braf inhibitor and a mek inhibitorHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0563US2024197735A1Methods and compositions comprising a braf inhibitor and a pd-1 binding antagonistHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0661US2024366605A1Use of quinazolinone compound for the treatment of cancerHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0758US2023322776A1New aryl-pyrido-pyrimidin-one derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0856US2022298145A1Braf inhibitors as paradox breakersHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0947US2025339432A1Quinazolinone compound as braf inhibitor for the treatment of advanced solid cancer or metastasesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Piergiorgio Francesco Tommaso Pettazzoni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →